联盛化学
(301212)
| 流通市值：23.74亿 | | | 总市值：27.35亿 |
| 流通股本：9375.00万 | | | 总股本：1.08亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 407,646,305.88 | 186,333,437.69 | 693,391,059.26 | 505,901,814.13 |
| 营业总成本 | 385,982,783.76 | 177,992,271.4 | 682,334,546.01 | 496,867,187.24 |
| 其他经营收益 | | | | |
| 营业利润 | 23,073,489.09 | 7,959,103.91 | 17,736,533.72 | 14,420,768.51 |
| 利润总额 | 23,040,020.67 | 7,946,838.17 | 17,329,359.62 | 14,182,154.48 |
| 净利润 | 21,083,142.48 | 7,108,849.99 | 16,443,175 | 13,767,146.33 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 21,083,142.48 | 7,108,849.99 | 16,443,175 | 13,767,146.33 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 676,070,056.45 | 670,763,106.39 | 709,049,396.55 | 680,664,114.43 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,128,655,976.83 | 1,088,924,313.32 | 1,083,012,535.7 | 1,056,860,962.59 |
| 资产总计 | 1,804,726,033.28 | 1,759,687,419.71 | 1,792,061,932.25 | 1,737,525,077.02 |
| 流动负债: | | | | |
| 流动负债合计 | 390,825,868.71 | 354,587,425.42 | 396,260,914.21 | 339,890,482.78 |
| 非流动负债: | | | | |
| 非流动负债合计 | 24,260,323 | 24,760,493.23 | 23,944,802.65 | 24,629,111.98 |
| 负债合计 | 415,086,191.71 | 379,347,918.65 | 420,205,716.86 | 364,519,594.76 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,357,704,424.82 | 1,349,442,743.55 | 1,341,977,480.35 | 1,340,764,501.82 |
| 股东权益合计 | 1,389,639,841.57 | 1,380,339,501.06 | 1,371,856,215.39 | 1,373,005,482.26 |
| 负债和股东权益合计 | 1,804,726,033.28 | 1,759,687,419.71 | 1,792,061,932.25 | 1,737,525,077.02 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 380,437,465.77 | 191,331,128.52 | 664,392,946.17 | 497,084,120.9 |
| 经营活动现金流出小计 | 388,830,495.59 | 185,938,049.35 | 556,485,208 | 430,020,793.69 |
| 经营活动产生的现金流量净额 | -8,393,029.82 | 5,393,079.17 | 107,907,738.17 | 67,063,327.21 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 70,638,466.22 | 48,458,074.19 | 293,062,352.2 | 269,945,468.72 |
| 投资活动现金流出小计 | 102,125,426.65 | 84,640,149.93 | 217,774,509.67 | 121,139,215.92 |
| 投资活动产生的现金流量净额 | -31,486,960.43 | -36,182,075.74 | 75,287,842.53 | 148,806,252.8 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 15,504,416.09 | 3,918,714.04 | 18,843,900.65 | 5,870,376.09 |
| 筹资活动现金流出小计 | 16,776,975.48 | 5,820,785.97 | 17,657,133.59 | 17,985,966.51 |
| 筹资活动产生的现金流量净额 | -1,272,559.39 | -1,902,071.93 | 1,186,767.06 | -12,115,590.42 |
| 汇率变动对现金及现金等价物的影响 | -2,075,279.14 | -667,033.19 | -1,430,669.61 | -622,010.68 |
| 现金及现金等价物净增加额 | -43,227,828.78 | -33,358,101.69 | 182,951,678.15 | 203,131,978.91 |
| 期末现金及现金等价物余额 | 200,193,644.24 | 210,063,371.33 | 243,421,473.02 | 263,601,773.78 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -43,227,828.78 | - | 182,951,678.15 | - |